Showing results (2101-2110 of 2,940) with videos related to
Sort By:
Pageof 294
Cancer Investigation|January 1, 1986
Growth and development of children born to patients after cancer therapyS C Gulati, R Vega, T Gee, et al.Cancer Investigation|January 1, 1986
In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosisS N Das, N N Khanna, S KhannaCancer Investigation|January 1, 1986
Short-term tests are unable to distinguish between human carcinogens and noncarcinogensF M Johnson, M L SnellCancer Investigation|June 3, 2014
BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patientsGulsah Cecener, Unal Egeli, Berrin Tunca, et al.Cancer Investigation|February 21, 2015
Decitabine treatment could ameliorate primary iron-overload in myelodysplastic syndrome patientsGu Shucheng, Chang Chunkang, Zhao Youshan, et al.Cancer Investigation|January 1, 1989
Immunoregulation of murine plasmacytoma. I. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104EI Hayashida, R N Hiramoto, K Shrestha, et al.Cancer Investigation|July 10, 2020
Impact of Non-Steroidal Anti-Inflammatory Drugs on Recurrence and Survival after Melanoma Surgery: A Cohort StudyBruno Luís de Castro Araujo, Jadivan Leite de Oliveira, José Francisco Neto Rezende, et al.Cancer Investigation|January 1, 1987
Natural killer cell activity of prostatic cancer patientsB K Choe, P Frost, M K Morrison, et al.Cancer Investigation|January 14, 2014
Prognostic value of p16 promoter hypermethylation in colorectal cancer: a meta-analysisWenjie Jiang, Pei-Ge Wang, Yuzhu Zhan, et al.Cancer Investigation|October 10, 2012
Patterns of response in patients with pretreated metastatic melanoma who received ipilimumab 3 mg/kg in a European expanded access program: five illustrative case reportsSofie Wilgenhof, Stephanie Du Four, Hendrik Everaert, et al.Pageof 294